BioCentury
ARTICLE | Politics & Policy

Midterms make Grassley Senate gatekeeper for pharma bills

November 7, 2018 6:24 PM UTC

The midterm election results could make Sen. Chuck Grassley (R-Iowa) the single most important politician in Washington to the biopharmaceutical industry.

In public statements over the past 24 hours, President Donald Trump, Senate Majority Leader Mitch McConnell (R-Ky.), and House Minority Leader Rep. Nancy Pelosi (D-Calif.) have identified reducing drug prices as an area of common ground. Pelosi is likely to become speaker of the House in the next Congress...